The Effects of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Platelet and Inflammatory Biomarkers in Patients with Metabolic Syndrome

By  

Cardiology, Vol. 125, Iss. 2, 2013-05 ,pp. : 74-77

Karger

Access to resources Recommend Favorite

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

By Catapano Alberico L.   Davidson Michael H.   Ballantyne Christie M.   Brady William E.   Gazzara Russell A.   Tomassini Joanne E.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2041-2053

Informa Healthcare

Access to resources Recommend Favorite

Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia

By Bays Harold   Sapre Aditi   Taggart William   Liu Ji   Capece Rachel   Tershakovec Andrew  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2953-2966

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias

By Wierzbicki Anthony S.   Doherty Emma   Lumb Peter J.   Chik George   Crook Martin A.  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 333-338

Informa Healthcare

Access to resources Recommend Favorite

Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice

By Hildemann Steven K.   Barho Christian   Karmann Barbara   Darius Harald   Bestehorn Kurt  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 713-719

Informa Healthcare

Access to resources Recommend Favorite